Targeting the mutated PI3Kα isoform for the development of novel anti-cancer agents

Project Information

COMPUT DRUG DESIGN

Grant agreement ID: 256533

Project closed

Start date 1 May 2010

End date 30 April 2014

Funded under

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 100 000,00

EU contribution € 100 000,00

Coordinated by

IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON
Greece